Dr. Yuxin Zhong 钟宇新
Chief Physician
Department of Pancreatic and Gastric Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of gastric cancer, pancreatic cancer, gastrointestinal stromal tumors, retroperitoneal liposarcomas, and pancreatic or gastric neuroendocrine tumors.
Dr. Zhong holds an MD from Peking Union Medical College (2002) and was a visiting scholar at Harvard Medical School’s Dana-Farber/Brigham and Women’s Cancer Center (2011–2012). The doctor has published over 50 articles and led more than 10 research projects.
Professional roles
- Vice Chair, Secretary-General, or Standing Committee Member of multiple national and Beijing academic committees
- Editorial Board Member of national core journals and health science magazines
Name order: in Chinese the family name comes first (Zhong Yuxin). Papers usually list the name as Yuxin Zhong or Zhong Y.
Selected publications
38 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Immunopathol Pharmacol, 2025 (senior author): Halofuginone induces ERK phosphorylation and synergizes with trametinib in gastric cancer cells. PubMed 40787830
- Asian Pac J Cancer Prev, 2024 (senior author): Intraperitoneal Irrigation Chemotherapy with Lobaplatin in Locally Advanced Gastric Cancer: A Special Type of Abdominal Chemotherapy. PubMed 39068574
- Front Oncol, 2024 (senior author): Intraoperative assessment of anastomotic blood supply using indocyanine green fluorescence imaging following esophagojejunostomy or esophagogastrostomy for gastric cancer. PubMed 38304873
- Front Oncol, 2023 (senior author): Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles. PubMed 37007142
- Front Oncol, 2023 (first author): Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study. PubMed 36741012
- Cancer Innov, 2022 (senior author): Research progress in the establishment of pancreatic cancer models and preclinical applications. PubMed 38089760
- Cancer Manag Res, 2020 (first author): Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles. PubMed 32636676
- Zhonghua Wei Chang Wai Ke Za Zhi, 2008 (first author): [Risk factors and surgical treatment of recurrent gastrointestinal stromal tumor in the rectum]. PubMed 19031131
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion